Secondary Hypersplenism
1 clinical trials · Condition
◉ Watch Secondary Hypersplenism
| Record | Firm | Date |
|---|---|---|
| A Single-Arm Clinical Trial of Percutaneous Splenic Ablation Combined With Splenic Artery Occlusion for Secondary Hypersplenism. (NCT06292715) | Tianjin Medical University Cancer Institute and Hospital | 2024-01-20 |
Track Secondary Hypersplenism automatically
Every clearance here is in the API, with alerts when new ones post.